As of 2025-08-08, the Relative Valuation of Redhill Biopharma Ltd (RDHL) is (48.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.17 USD, the upside of Redhill Biopharma Ltd based on Relative Valuation is -4252.2%.
The range of the Relative Valuation is (26.97) - (50.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.9x - 30.0x | 18.0x |
| Forward P/E multiples | 8.3x - 15.6x | 12.0x |
| Fair Price | (26.97) - (50.69) | (48.58) |
| Upside | -2405.2% - -4432.8% | -4252.2% |
| Date | P/E |
| 2025-08-07 | -0.36 |
| 2025-08-06 | -0.38 |
| 2025-08-05 | -0.38 |
| 2025-08-04 | -0.37 |
| 2025-08-01 | -0.37 |
| 2025-07-31 | -0.40 |
| 2025-07-30 | -0.45 |
| 2025-07-29 | -0.46 |
| 2025-07-28 | -0.50 |
| 2025-07-25 | -0.53 |
| 2025-07-24 | -0.56 |
| 2025-07-23 | -0.62 |
| 2025-07-22 | -0.67 |
| 2025-07-21 | -0.72 |
| 2025-07-18 | -0.57 |
| 2025-07-17 | -0.74 |
| 2025-07-16 | -0.60 |
| 2025-07-15 | -0.59 |
| 2025-07-14 | -0.67 |
| 2025-07-11 | -0.67 |
| 2025-07-10 | -0.66 |
| 2025-07-09 | -0.64 |
| 2025-07-08 | -0.65 |
| 2025-07-07 | -0.63 |
| 2025-07-03 | -0.62 |
| 2025-07-02 | -0.62 |
| 2025-07-01 | -0.62 |
| 2025-06-30 | -0.60 |
| 2025-06-27 | -0.57 |
| 2025-06-26 | -0.56 |
| 2025-06-25 | -0.58 |
| 2025-06-24 | -0.60 |
| 2025-06-23 | -0.58 |
| 2025-06-20 | -0.58 |
| 2025-06-18 | -0.57 |
| 2025-06-17 | -0.54 |
| 2025-06-16 | -0.55 |
| 2025-06-13 | -0.54 |
| 2025-06-12 | -0.60 |
| 2025-06-11 | -0.62 |
| 2025-06-10 | -0.62 |
| 2025-06-09 | -0.63 |
| 2025-06-06 | -0.61 |
| 2025-06-05 | -0.59 |
| 2025-06-04 | -0.59 |
| 2025-06-03 | -0.57 |
| 2025-06-02 | -0.55 |
| 2025-05-30 | -0.55 |
| 2025-05-29 | -0.54 |
| 2025-05-28 | -0.55 |